Under construction – not a live service
Sign in
Taking people in SwitzerlandNo phase

Imaging blood flow during stroke clot removal in patients with acute ischemic stroke

Studies a new 3D imaging method during clot removal in adults with ischemic stroke.

Plain-language title generated from the registry record
Registry title: PeRfusiOn Post tHrombEcTomy (PROPHET)

Key facts

Where
Basel and Bern, SwitzerlandSee the 2 sites

Where in Switzerland

  • University Hospital BaselBasel, SwitzerlandNot yet recruiting
  • University Hospital BernBern, SwitzerlandTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
Insel Gruppe AG, University Hospital Bern
Trial code
NCT06691230
Record updated
15 November 2024
Original description
Endovascular mechanical thrombectomy is the standard of care for treating patients with a large-vessel occlusion acute ischemic stroke. However, in more than half of these patients, remaining distal vessel occlusions limit the benefit of this therapy. Currently the detection of residual vessel occlusions and the decision for further treatment by the operator is based on the 2D digital subtraction angiography (DSA) images. However, this technique has several limitations. Recently, a new imaging technique, with the possibility to acquire 3D time-resolved perfusion images directly in the operating room was introduced (the flat-panel detector computed tomography perfusion imaging, FDCTP). It can overcome the spatial limitations of 2D DSA, but the details on clinical validation and utility of FDCTP are currently lacking.Read full original descriptionShow less

PeRfusiOn Post tHrombEcTomy (PROPHET) A Prospective Observational Cohort Study

Endovascular mechanical thrombectomy is the standard of care for treating patients with a large-vessel occlusion acute ischemic stroke. However, in more than half of these patients, remaining distal vessel occlusions limit the benefit of this therapy. Currently the detection of residual vessel occlusions and the decision for further treatment by the operator is based on the 2D digital subtraction angiography (DSA) images. However, this technique has several limitations. Recently, a new imaging technique, with the possibility to acquire 3D time-resolved perfusion images directly in the operating room was introduced (the flat-panel detector computed tomography perfusion imaging, FDCTP). It can overcome the spatial limitations of 2D DSA, but the details on clinical validation and utility of FDCTP are currently lacking.

Inclusion: Informed consent as documented by a signature; The patients received mechanical thrombectomy or there was the intention to perform endovascular treatment, but only diagnostic angiography was performed; Patients received FDCTP as clinically indicated by the treating physician.

Exclusion: Inability to follow the clinically indicated visit at 90 days after the index stroke (e.g. patients living abroad); Inability to give consent due to insufficient knowledge of the project language.

ClinicalTrials.gov NCT06691230